Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
183.34
-2.34 (-1.26%)
Oct 7, 2024, 4:00 PM EDT - Market closed

Biogen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
9,6729,83610,17310,98212,67013,670
Upgrade
Other Revenue
----774.6707.7
Upgrade
Revenue
9,6729,83610,17310,98213,44514,378
Upgrade
Revenue Growth (YoY)
-3.00%-3.32%-7.36%-18.32%-6.49%6.88%
Upgrade
Cost of Revenue
2,2782,5332,2782,1101,8051,955
Upgrade
Gross Profit
7,3947,3027,8958,87211,63912,423
Upgrade
Selling, General & Admin
2,4892,5022,4092,6802,5162,359
Upgrade
Research & Development
2,2122,4582,2292,4973,9852,273
Upgrade
Other Operating Expenses
232.8218.8-7.47.2232.9241.6
Upgrade
Operating Expenses
5,2375,4204,8775,4366,9885,147
Upgrade
Operating Income
2,1581,8823,0193,4364,6517,275
Upgrade
Interest Expense
-265.8-246.9-246.6-250.4-213.1-187.4
Upgrade
Interest & Investment Income
157.2276.589.31142120
Upgrade
Earnings From Equity Investments
--2.634.95.3-79.4
Upgrade
Currency Exchange Gain (Loss)
-51.7-50.4-35.5-22.4-10.7-7
Upgrade
Other Non Operating Income (Expenses)
-3.9-1.7-7.1-47.8-44.4
Upgrade
EBT Excluding Unusual Items
1,9931,8602,8213,2054,4827,077
Upgrade
Merger & Restructuring Charges
-387.8-271.7-131.1---27.7
Upgrade
Gain (Loss) on Sale of Investments
-380.2-291.21,228-824.9685.7204.7
Upgrade
Gain (Loss) on Sale of Assets
--503.7-92.5-55.3
Upgrade
Asset Writedown
---119.6-629.3-209.7-215.9
Upgrade
Legal Settlements
---917---
Upgrade
Other Unusual Items
88.6-209.147.576.963.7
Upgrade
Pretax Income
1,3141,2973,5941,7805,0537,047
Upgrade
Income Tax Expense
156.3135.3632.852.5992.31,158
Upgrade
Earnings From Continuing Operations
1,1581,1622,9621,7284,0615,889
Upgrade
Minority Interest in Earnings
1-0.485.3-171.5-59.9-
Upgrade
Net Income
1,1591,1613,0471,5564,0015,889
Upgrade
Net Income to Common
1,1591,1613,0471,5564,0015,889
Upgrade
Net Income Growth
-56.52%-61.89%95.80%-61.10%-32.06%32.90%
Upgrade
Shares Outstanding (Basic)
145145145149161187
Upgrade
Shares Outstanding (Diluted)
146146146150161187
Upgrade
Shares Change (YoY)
0.38%-0.27%-2.41%-7.25%-13.93%-8.72%
Upgrade
EPS (Basic)
7.988.0220.9710.4424.8631.47
Upgrade
EPS (Diluted)
7.947.9720.8710.4024.8031.42
Upgrade
EPS Growth
-56.73%-61.81%100.67%-58.06%-21.07%45.60%
Upgrade
Free Cash Flow
1,5651,2701,1443,3823,8056,564
Upgrade
Free Cash Flow Per Share
10.738.727.8422.6123.5935.03
Upgrade
Gross Margin
76.45%74.24%77.61%80.79%86.57%86.40%
Upgrade
Operating Margin
22.31%19.14%29.67%31.29%34.59%50.60%
Upgrade
Profit Margin
11.98%11.81%29.95%14.17%29.76%40.96%
Upgrade
Free Cash Flow Margin
16.18%12.91%11.25%30.79%28.30%45.65%
Upgrade
EBITDA
2,7292,3773,5373,9235,1087,740
Upgrade
EBITDA Margin
28.22%24.17%34.77%35.73%38.00%53.83%
Upgrade
D&A For EBITDA
571.5494.8518.4487.7457.2464.7
Upgrade
EBIT
2,1581,8823,0193,4364,6517,275
Upgrade
EBIT Margin
22.31%19.14%29.67%31.29%34.59%50.60%
Upgrade
Effective Tax Rate
11.90%10.43%17.61%2.95%19.64%16.43%
Upgrade
Revenue as Reported
9,6729,83610,17310,98213,44514,378
Upgrade
Advertising Expenses
-71.454.198.7111.879.2
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.